The stock market continues to defy expectations. Even more surprising, a few PIPCOs have dramatically outperformed it. Smaller cap patent stocks have not fared so
The stock market continues to defy expectations. Even more surprising, a few PIPCOs have dramatically outperformed it. Smaller cap patent stocks have not fared so
The rights to an expensive drug treatment owned by the Cystic Fibrosis Foundation has helped it to reap a financial windfall but is not without
As businesses adjust to new judicial and legislative requirements public patent licensing companies will have to work harder and think smarter to compete against the
With three recent Markman hearings and more than $100M in cash UPIP trading currently at $1.46 could be a good buy for those with patience
Expect a transaction to yield some clues about which smart phone-related patents are interesting, what they are worth and to whom. Struggling South Korean handset
What’s to be learned from PwC’s 2014 Patent Litigation Survey that we don’t already know? Patent suits are at an all-time high, with almost 6,500
While $50 million-and-up patent verdicts were up in the first half of 2014, there were only two wins higher than $131M and none from NPEs.
Coming up with better ideas for communication and transportation is nothing new. British Pathe captured many of the 20th Century’s most innovative on film. A
Finjan, Inventergy, Network-1, Straight Talk and Universal Display have been added to the IP licensing company (PIPCO) stock index, IP Close Up 30. To remain
Despite their increased size and capital most small public companies that rely significantly on patent licensing have yet to prove they can compete with other
Seven of the top ten plaintiffs with the most patents asserted in cases open in 2013 are operating companies. Data presented in a report released
In the days preceding what could be the largest U.S. IPO ever, Alibaba, the Chinese e-commerce giant, has been buying patents as well as filing